PHOX2B and neuroblastoma: Mutations in PHOX2B and RAS pathway genes were previously reported in 2.3% and 3.7% of neuroblastoma cases [18, 19], but such mutations were less frequent in our screen here (Figure 1, Supplementary Table 1).